Atrium Therapeutics (RNA) Stock Insights
RNA$8.21-0.11 -1.32%
$140.44M
Market Cap
-2.13
P/E
—
Forward P/E
67
Score
Atrium Therapeutics (RNA) Stock Insights
RNA price $8.21 -0.11 -1.32%
- Ticker
- RNA
- Price
- $8.21
- Change
- -0.11 -1.32%
- Market cap ?
- $140.44M
- P/E ?
- -2.13
- Dividend yield ?
- 0.00%
- Beta ?
- 0.37
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 67
- Value
- 53
- Quality
- 48
- Growth
- 100
Stocklytics score rationale: value 53, quality 48, growth 100.
Financials
| 2025 |
|---|
| 18618000 |
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to…
Fair value
RNA fair value Not meaningful. Price $8.21.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.81 | — | 15.00M |
| 2026-08-13 | -1.18 | -1.42 | 3.00M | 666.67K |
| 2026-05-14 | -0.97 | -1.05 | 19.64M | 2.00M |
| 2026-02-26 | -0.61 | -1.24 | 2.10M | 1.98M |
| 2025-05-08 | -0.90 | -0.90 | — | 2.37M |
| 2025-02-27 | -0.80 | -0.79 | — | 1.63M |
| 2024-11-07 | -0.65 | -0.71 | — | 4.07M |
| 2024-08-09 | -0.65 | -0.79 | — | 2.62M |
| 2024-05-09 | -0.79 | -0.78 | — | 2.57M |
| 2024-02-28 | -0.79 | -0.66 | — | 12.21M |
| 2023-11-08 | -0.71 | -0.77 | — | 2.21M |
| 2023-08-08 | -0.66 | -0.80 | — | 2.14M |
| 2023-05-09 | -0.74 | -0.85 | — | 2.04M |
| 2023-02-28 | -0.88 | -0.89 | — | 2.16M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Younis Husam | Sell | 11.22K | $8.95 | 100.38K |
| 2026-09-18 | Hughes Steven George | Sell | 21.46K | $8.95 | 192.06K |
| 2026-09-18 | Flanagan W. Michael | Sell | 22.81K | $8.95 | 204.17K |
| 2026-09-18 | Boyce Sarah | Sell | 126.42K | $8.95 | 1.13M |
| 2026-09-18 | Kenney Stephanie | Sell | 2.38K | $8.95 | 21.26K |
| 2026-09-18 | Gallagher Kathleen P. | Sell | 11.63K | $8.95 | 104.11K |
| 2026-09-18 | Winslow Brendan R. | Sell | 6.74K | $8.95 | 60.34K |
| 2026-09-18 | Hoyos Rocio Martin | Sell | 8.32K | $8.95 | 74.46K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 159, holders -9 vs prior quarter. Ownership 84.59%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| SESSA CAPITAL IM, L.P. | 1.50M | 948.61K | +172.04% | 20.18M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.47M | -80.23K | -5.17% | 19.81M |
| BLACKROCK, INC. | 1.45M | 242.19K | +20.09% | 19.47M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 840.60K | 829.26K | +7310.74% | 11.31M |
| VANGUARD CAPITAL MANAGEMENT LLC | 730.83K | 103.96K | +16.58% | 9.83M |
| CRCM LP | 641.54K | 641.54K | New | 8.63M |
| TIG ADVISORS, LLC | 561.53K | -46.02K | -7.57% | 7.55M |
| GEODE CAPITAL MANAGEMENT, LLC | 386.93K | 67.10K | +20.98% | 5.21M |
| TWO SIGMA INVESTMENTS, LP | 345.48K | 166.92K | +93.48% | 4.65M |
| GOLDMAN SACHS GROUP INC | 310.34K | -39.61K | -11.32% | 4.17M |
| 683 CAPITAL MANAGEMENT, LLC | 300.00K | 0 | 0.00% | 4.04M |
| STATE STREET CORP | 271.76K | 14.68K | +5.71% | 3.66M |
| ARBITER PARTNERS CAPITAL MANAGEMENT LLC | 261.29K | 31.29K | +13.60% | 3.51M |
| CANTOR FITZGERALD, L. P. | 256.92K | 21.28K | +9.03% | 3.46M |
| SLOTNIK CAPITAL, LLC | 237.64K | 56.69K | +31.33% | 3.20M |
| WEISS ASSET MANAGEMENT LP | 219.73K | -20.97K | -8.71% | 2.96M |
| MILLENNIUM MANAGEMENT LLC | 200.56K | 9.70K | +5.08% | 2.70M |
| SCHONFELD STRATEGIC ADVISORS LLC | 199.16K | 36.40K | +22.36% | 2.68M |
| AQR CAPITAL MANAGEMENT LLC | 172.24K | 172.24K | New | 2.32M |
| NEXPOINT ASSET MANAGEMENT, L.P. | 150.03K | 0 | 0.00% | 2.02M |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 150.00K | 80.00K | +114.29% | 2.02M |
| SQUAREPOINT OPS LLC | 146.74K | -84.72K | -36.60% | 1.97M |
| BRACEBRIDGE CAPITAL, LLC | 139.24K | 0 | 0.00% | 1.87M |
| NOMURA HOLDINGS INC | 137.39K | 14 | +0.01% | 1.85M |
| YAKIRA CAPITAL MANAGEMENT, INC. | 133.05K | 6.40K | +5.06% | 1.79M |
Insights · Dividends · Forecast · Financials · Learn